Inflectra (Infliximab)
Complete patient guide for uses, dosage, side effects, and safety information
Prescription RequiredQuick Facts
What Is Inflectra Used For?
Inflectra contains infliximab, a monoclonal antibody that helps reduce inflammation in various autoimmune conditions. It’s an approved biosimilar medicine with proven safety and effectiveness.
Primary Uses
Inflectra treats rheumatoid arthritis (reduces joint inflammation and prevents damage), ankylosing spondylitis (reduces spine inflammation), psoriatic arthritis (reduces joint inflammation and improves function), moderate to severe psoriasis (for patients not responding to other treatments), moderate to severe Crohn’s disease (in adults and children 6-17 years), and ulcerative colitis (in adults and children 6-17 years). It can also help close abnormal openings from the bowel in Crohn’s disease.
How It Works
Inflectra works by binding to a protein called tumor necrosis factor alpha (TNFα). In autoimmune diseases, your body produces too much TNFα, causing your immune system to attack healthy tissues. By blocking TNFα, Inflectra prevents this damage and reduces inflammation.
Good to know: Inflectra is made from human and mouse proteins using advanced technology and has been proven comparable to the original infliximab medicine.
How to Take Inflectra
Inflectra is given as an intravenous infusion (drip into a vein) in a healthcare setting under medical supervision. The infusion takes at least 2 hours, followed by an observation period.
Dosage Instructions
Rheumatoid arthritis: 3 mg/kg initially, then at 2 and 6 weeks, then every 8 weeks (may increase to 7.5 mg/kg if needed). Ankylosing spondylitis: 5 mg/kg initially, then at 2 and 6 weeks, then every 6 weeks. Psoriatic arthritis and psoriasis: 5 mg/kg initially, then at 2 and 6 weeks, then every 8 weeks. Crohn’s disease and ulcerative colitis: 5 mg/kg initially, then at 2 and 6 weeks, then every 8 weeks (may increase to 10 mg/kg for Crohn’s if needed). For children and adolescents (6-17 years), infusions are always given over at least 2 hours.
What If You Miss a Dose?
Since Inflectra is given under medical supervision, you’re unlikely to miss a dose. If you forget or miss your appointment, schedule another as soon as possible. Your doctor will determine when and how much your next dose should be.
Important: After tolerating the first 3 two-hour infusions, your doctor may reduce future infusion times to not less than 1 hour (except for children who always need at least 2 hours).
Side Effects
Like all medications, this medicine can cause side effects. Most are mild and temporary, but some require medical attention.
Common Side Effects
These side effects occur relatively frequently and usually don’t require emergency care:
- Fever or chills during infusion
- Itchiness or hives
- Chest pain
- Blood pressure changes
- Shortness of breath
- Skin rash
- Flushing
- Dry skin or increased sweating
- Nausea or vomiting
- Abdominal pain
- Diarrhea
- Fatigue
- Headache
- Dizziness
- Sore throat
- Cough
- Weight changes
- Muscle pain
- Back pain
Seek immediate medical attention if you experience:
- Signs of serious infection (fever, persistent cough, weight loss)
- Tuberculosis symptoms
- Hepatitis B symptoms (jaundice, dark urine, abdominal pain)
- Severe allergic reactions
- Heart failure symptoms (shortness of breath, swelling)
- Numbness or paralysis
- Blurred or darkened vision
- Severe liver problems
- New or worsening autoimmune conditions
- Signs of blood disorders
- New skin lesions or changes in existing ones
Cancer Risk
Inflectra may increase your risk of certain cancers including lymphoma, skin cancers, and in rare cases, a type called Hepatosplenic T-cell Lymphoma in young patients with Crohn’s disease or ulcerative colitis. Women may have increased cervical cancer risk and should continue regular screening. Patients with lung disease and smoking history may have increased cancer risk.
Important Warnings
Inflectra affects your immune system and can increase your risk of serious infections and certain cancers. Your doctor will monitor you closely throughout treatment.
Who Should Not Take Inflectra
Do not use Inflectra if you’re allergic to mouse proteins or any ingredients, have severe infections like tuberculosis or infected abscesses, have recurring infections, are taking anakinra (another arthritis medicine), or have congestive heart failure and have never received Inflectra before.
Medical Conditions to Discuss
Tell your doctor if you have current infections or infection history, tuberculosis exposure or history, hepatitis B exposure or history, lived in areas with fungal infections (histoplasmosis, coccidioidomycosis, blastomycosis), cancer history, nervous system diseases (multiple sclerosis, seizures), congestive heart failure, blood disorders, planned surgeries, or need vaccinations. Also discuss if you have long-standing active disease as you may have higher infection and lymphoma risks.
Pregnancy and Breastfeeding
Inflectra is not recommended during pregnancy as it crosses the placenta and can be detected in babies for up to 12 months after birth. Use effective contraception for at least 6 months after your last infusion. Inflectra passes into breast milk, so discuss risks and benefits with your doctor. If you have a baby while using Inflectra, wait 12 months before giving your baby live vaccines.
Serious Infection Risk: Inflectra increases your risk of serious infections including tuberculosis and sepsis. Report any signs of infection immediately to your doctor.
Drug Interactions
Several medications can interact with Inflectra or affect how well it works. Always tell your healthcare providers about all medications you’re taking.
Vaccination Important: Update all vaccines before starting Inflectra if possible, as some vaccines cannot be given during treatment.
- Anakinra (do not use together)
- Abatacept (tell your doctor if taking)
- Other arthritis treatments
- Phototherapy or other psoriasis treatments
- Crohn’s disease or ulcerative colitis treatments
- Organ transplant rejection prevention medicines
- Live vaccines (should not be given during treatment)
- Therapeutic infectious agents for cancer treatment
Alcohol & Driving
Inflectra is unlikely to affect your ability to drive or operate machinery, but you should be cautious if you feel tired or unwell.
Alcohol
No specific alcohol interactions are mentioned, but discuss alcohol use with your doctor as it may affect your overall health and immune system.
Driving and Operating Machinery
Inflectra is unlikely to make you drowsy, but if you feel tired or unwell, do not drive or operate machinery until you feel better.
Storage
Inflectra is stored and prepared by healthcare professionals in clinical settings. You do not need to store this medication at home as it is only given in healthcare facilities.
Overdose Information
Since Inflectra is given under medical supervision, overdose is very unlikely. However, if you think you or someone else has received too much Inflectra, immediately tell your doctor, call the Poisons Information Centre at 13 11 26, or go to the nearest hospital emergency department, even if there are no symptoms.
Frequently Asked Questions
The timing varies by condition. For rheumatoid arthritis, your doctor will assess your response after 12 weeks of treatment. You receive doses at specific intervals (initially, then at 2 and 6 weeks, then regularly every 6-8 weeks depending on your condition).
Some vaccines should not be given while you’re being treated with Inflectra, particularly live vaccines. If possible, you should update all your vaccines before starting Inflectra treatment. Always tell your doctor you’re taking Inflectra before receiving any vaccination.
Tell your doctor immediately if you think you have an infection. Inflectra affects your immune system and you may be more prone to infections. Watch for symptoms like persistent cough, weight loss, fever, or any signs of tuberculosis or hepatitis B.
Tell your doctor you are using Inflectra before any surgical procedures. Your doctor may need to delay treatment with Inflectra if you have planned surgery and will discuss the timing with you.
Some side effects may appear several weeks or even months after stopping Inflectra treatment. Continue to watch for skin rash, hives, frequent infections, tuberculosis symptoms, or hepatitis B symptoms and report them to your doctor immediately even after treatment ends.
Inflectra is not recommended during pregnancy. It crosses the placenta and can be detected in babies for up to 12 months after birth. You must use effective contraception for at least 6 months after your last Inflectra infusion to avoid pregnancy.
Inflectra has been detected in breast milk. Your doctor will discuss whether the benefits of Inflectra treatment for you outweigh the potential risks to your infant while breastfeeding.
Important Disclaimer
This information is intended for general educational purposes only and should not be considered medical advice. Always consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.
If you think you may have a medical emergency, call your doctor or emergency services immediately.